Sermorelin/ GHRH

Buy Sermorelin: The Shortest GHRH Analogue for Growth Axis Research

Looking for a trusted source to buy Sermorelin? Sino Research Peptide Manufacturer supplies high-purity Sermorelin peptide, formulated specifically for laboratory and research use. Below, you’ll find a full research overview of this compact GHRH analogue, along with everything you need to know before you buy Sermorelin online.

What Is Sermorelin Peptide?

Sermorelin is a 29 amino acid peptide — the shortest synthetically developed peptide that may induce biological activity at growth hormone-releasing hormone (GHRH) receptors. It functions as an analog of the GHRH factor, consisting of GHRH (1-29 acid)-amide. Because of this structural and functional mimicry, researchers have studied Sermorelin across multiple branches of growth hormone deficiency research.

A Brief Research History

Scientists first explored Sermorelin’s action in the early 1980s, classifying it as a growth hormone-releasing fragment, GHRF (1-29) amide. Early rat studies introduced exogenous GHRF (1-29) amide in both conscious and anesthetized animals, and researchers observed that its presence appeared to stimulate the pituitary gland and promote growth. This theory sparked further research into Sermorelin and similar compounds within growth hormone deficiency models.

How Does Sermorelin Work?

Sermorelin constitutes the first 29 amino acids of the usual 44 found in growth hormone-releasing hormone (GHRH). Researchers believe it binds with GHRH receptors on the pituitary gland, potentially stimulating secretion of growth hormone (hGH). In this way, Sermorelin appears to maintain GHRH’s fundamental function despite its shortened amino acid sequence, possibly leading to sporadic growth hormone release and, in turn, increased insulin-like growth factor-1 (IGF-1) levels.

The estimated half-life of Sermorelin sits around 11 to 12 minutes. One notable advantage is its apparent GHRH receptor specificity — because of this, Sermorelin may not significantly affect other endocrine markers such as prolactin, insulin, cortisol, glucose, or thyroid hormones.

The cAMP-PKA Signalling Pathway

Sermorelin is thought to interact with GHRH receptors through complex molecular mechanisms, possibly triggering various cellular signaling pathways. Upon binding, it may alter the receptor’s structure and initiate intracellular signaling events. Some researchers propose that Sermorelin enhances cAMP production through adenylate cyclase activation, which converts ATP into cAMP.

Higher cAMP levels may activate protein kinase A (PKA), a key enzyme in cellular signaling. PKA may then phosphorylate target proteins, triggering further cellular responses. This cascade is thought to promote hGH secretion from somatotroph cells in the pituitary gland, which in turn contributes to IGF-1 synthesis.

Chemical Makeup

Sermorelin Acetate Benefits: What Does the Research Say?

Before you buy Sermorelin online, it helps to understand what current research suggests about its potential applications. Below, we break down the key study areas.

Buy Sermorelin and Growth Velocity

Researchers reported positive results in idiopathic GH deficiency models when Sermorelin was presented to underdeveloped animal subjects. Increased growth and height velocity emerged within 12 months of consistent, continuous peptide presence, and these elevated levels appeared to sustain for an average of 36 months afterward.

Buy Sermorelin and Anabolic Research Outcomes

Preliminary findings from one investigation indicate that Sermorelin may lead to an 82% enhancement in average growth hormone levels, with actions persisting for approximately two hours. A separate 16-week study suggests Sermorelin might elevate growth hormone levels by as much as 107% and increase IGF-1 levels by about 28%. This research also points to a possible increase in lean body mass of approximately 2.78 lbs (1.26 kg), with no significant change in fat mass.

Sermorelin and Lipodystrophy

A controlled clinical study involving 31 HIV-positive subjects with lipodystrophy divided participants into a Sermorelin group and a placebo group over 12 weeks. Researchers suggested growth hormone levels increased significantly in the Sermorelin group compared to placebo, alongside apparent increases in IGF-1 and lean body mass. Abdominal visceral fat and the ratio of trunk-to-lower-extremity fat were reported significantly reduced, with no other changes in glucose or insulin levels.

Sermorelin and Cognition

Clinical research in the early 2000s involved 89 subjects between 68 and 69 years old, exploring the link between tapering growth hormone release and cognitive changes that can accompany aging. Following Sermorelin introduction, researchers observed improved performance on the Wechsler Adult Intelligence Scale (WAIS), including IQ levels, picture arrangement tests, and verbal tests.

Buy Sermorelin and Tumor Cell Research

In one clinical study, researchers presented 1,018 glioma subjects with over 4,000 compounds each and determined a drug response score (DRS) for every compound. Sermorelin reportedly induced the most sensitivity among the tested compounds. Researchers suggested this might relate to Sermorelin’s potential to block tumor cell cycles, possibly preventing tumor cell proliferation.

Does Sermorelin Increase Testosterone?

Initial research explored whether Sermorelin held potential relevance to hypogonadism. In one study, test models received Sermorelin followed by GHRH 1-40 (or the reverse order), with a one-week interval between compounds. Researchers reported that Sermorelin appeared to stimulate the release of FSH and LH, which might in turn stimulate testosterone production.

This research prompted a follow-up study involving 19 male subjects: 9 aged between 22 and 33, and 10 aged between 60 and 78. The older subjects received one of two Sermorelin concentrations over 28 days, with a 14-day interval between doses. Testosterone levels in these subjects reportedly increased following Sermorelin presentation, though researchers noted the changes were not statistically significant. Elevated growth hormone levels, possibly linked to Sermorelin, appeared highest at night across all subjects compared to daytime measurements.

Sermorelin Timing in Research Protocols

Questions like “can you take Sermorelin in the morning” relate to administration timing within a specific research protocol. Since dosing schedules depend entirely on the study design and institutional guidelines, we recommend consulting your institution’s approved research protocols before beginning any study involving this peptide.

Where to Buy Sermorelin Online

Where to Buy Sermorelin

If you’ve been searching for where to buy Sermorelin, Sino Research Peptide Manufacturer offers a straightforward, reliable path to research-grade material. Every batch ships with purity verification, so you always know exactly what you’re working with.

Best Place to Buy Sermorelin

Researchers looking for the best place to buy Sermorelin choose Sino Research Peptide Manufacturer for consistent quality control, transparent documentation, and dependable supply.

Sermorelin for Sale Online

We keep Sermorelin for sale online, with fast, tracked dispatch to laboratories and research institutions. Whether you’re placing your first order or restocking for an ongoing study, our streamlined process keeps your research moving.

Important Research Notice

Sermorelin peptide is available for research and laboratory purposes only. It is not intended for human or veterinary use. Please review and adhere to our Terms and Conditions before placing an order.

• References:

  1. Garcia JM, Merriam GR, Kargi AY. Growth Hormone in Aging. [Updated 2019 Oct 7]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. https://www.ncbi.nlm.nih.gov/books/NBK279163/?report=reader
  2. Prakash, A, and K L Goa. “Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.” BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 12,2 (1999): 139-57. https://pubmed.ncbi.nlm.nih.gov/18031173/
  3. National Center for Biotechnology Information. “PubChem Compound Summary for CID 16129620, Sermorelin” PubChem
  4. Clark, R G, and I C Robinson. “Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient rats.” Nature vol. 314,6008 (1985): 281-3. https://pubmed.ncbi.nlm.nih.gov/2858818/
  5. Drugs at FDA: FDA Approved Drugs. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020443
  6. Junichi I. et al, Growth hormone secretagogues: history, mechanism of action, and clinical development, JSCM Rapid Communications Vol. 3 Issue 1, 09 February 2020. https://onlinelibrary.wiley.com/doi/full/10.1002/rco2.9
  7. Prakash, A, and K L Goa. “Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.” BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 12,2 (1999): 139-57. https://pubmed.ncbi.nlm.nih.gov/18031173/
  8. Koutkia, Polyxeni et al. “Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.” JAMA vol. 292,2 (2004): 210-8. https://pubmed.ncbi.nlm.nih.gov/15249570/
  9. Vitiello, Michael V et al. “Growth hormone releasing hormone improves the cognition of healthy older adults.” Neurobiology of aging vol. 27,2 (2006): 318-23. https://pubmed.ncbi.nlm.nih.gov/16399214/
  10. Chang, Yuanhao et al. “A potentially effective drug for patients with recurrent glioma: sermorelin.” Annals of translational medicine vol. 9,5 (2021): 406. doi:10.21037/atm-20-6561. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033379/
  11. Sinha, Deepankar K et al. “Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.” Translational andrology and urology vol. 9,Suppl 2 (2020): S149-S159. doi:10.21037/tau.2019.11.30. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108996/
  12. Zhou, F., Zhang, H., Cong, Z., Zhao, L. H., Zhou, Q., Mao, C., Cheng, X., Shen, D. D., Cai, X., Ma, C., Wang, Y., Dai, A., Zhou, Y., Sun, W., Zhao, F., Zhao, S., Jiang, H., Jiang, Y., Yang, D., Eric Xu, H., … Wang, M. W. (2020). Structural basis for activation of the growth hormone-releasing hormone receptor. Nature communications, 11(1), 5205. https://doi.org/10.1038/s41467-020-18945-0
  13. Vittone, J., Blackman, M. R., Busby-Whitehead, J., Tsiao, C., Stewart, K. J., Tobin, J., Stevens, T., Bellantoni, M. F., Rogers, M. A., Baumann, G., Roth, J., Harman, S. M., & Spencer, R. G. (1997). Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism: clinical and experimental, 46(1), 89–96. https://doi.org/10.1016/s0026-0495(97)90174-8
  14. Khorram, O., Laughlin, G. A., & Yen, S. S. (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. The Journal of clinical endocrinology and metabolism, 82(5), 1472–1479. https://doi.org/10.1210/jcem.82.5.3943